The new inhaler replaces Trixeo Aerosphere’s existing gas propellant with a low global warming-potential alternative.

Patients with COPD and chronic hypercapnic respiratory failure on noninvasive ventilation report similar quality of life ...

While numerous studies have assessed how much people with chronic obstructive pulmonary disease (COPD) walk, few have explored how they walk, especially in unsupervised, ...

Across four prospective U.S. cohorts, 4.5% of those 18-49 years old met criteria for COPD, defined as spirometric airflow ...

The pivotal Phase IIb ALIENTO study met its primary endpoint and showed that astegolimab reduced the annualized exacerbation rate (AER) by a statistically significant 15.4% at 52 weeks, when given ...

The path to market for Roche’s astegolimab became more uncertain after the investigational antibody failed to significantly ...

Roche’s hopes of getting its chronic obstructive pulmonary disease (COPD) drug astegolimab to regulators this year have taken ...

Urine VOCs are linked to COPD risk and inflammation in NHANES data, suggesting potential for non-invasive screening with ...

Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing will ...

Astegolimab from Roche's Genentech fails phase 3 COPD trial, reflecting challenges in monoclonal antibody treatment for the ...

Residents including parents of children who have received care for two conditions — asthma and chronic obstructive pulmonary disease — have been asked to assist in guiding the island’s healthcare ...

Obama officials omitted Russian intel on Hillary Clinton’s alleged health problems while saying Russian President Vladimir Putin aimed to help President Donald Trump, according to newly declassified ...